These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35990796)

  • 1. Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders.
    Martins B; Rutland W; De Aquino JP; Kazer BL; Funaro M; Potenza MN; Angarita GA
    Curr Addict Rep; 2022; 9(4):647-659. PubMed ID: 35990796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review.
    Edinoff AN; Wu NW; Nix CA; Bonin B; Mouhaffel R; Vining S; Gibson W; Cornett EM; Murnane KS; Kaye AM; Kaye AD
    Health Psychol Res; 2022; 10(4):38672. PubMed ID: 36628122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study.
    Aharonovich E; Liu X; Samet S; Nunes E; Waxman R; Hasin D
    Am J Psychiatry; 2005 Aug; 162(8):1507-14. PubMed ID: 16055773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.
    Garel N; McAnulty C; Greenway KT; Lesperance P; Miron JP; Rej S; Richard-Devantoy S; Jutras-Aswad D
    Drug Alcohol Depend; 2022 Oct; 239():109606. PubMed ID: 36087563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Treatment of Alcohol Cravings.
    Marin MCD; Pedro MOP; Perrotte G; Martins-da-Silva AS; Lassi DLS; Blaas IK; Castaldelli FI; Brisola Dos Santos MB; Kortas GT; Campos MW; Torales J; Ventriglio A; Périco CA; Negrão AB; Leopoldo K; de Andrade AG; Malbergier A; Castaldelli-Maia JM
    Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence.
    Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R
    Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.
    Haney M
    Addict Biol; 2009 Jan; 14(1):9-21. PubMed ID: 18855806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review.
    Jones JL; Mateus CF; Malcolm RJ; Brady KT; Back SE
    Front Psychiatry; 2018; 9():277. PubMed ID: 30140240
    [No Abstract]   [Full Text] [Related]  

  • 10. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.
    Compton WM; Dawson DA; Goldstein RB; Grant BF
    Drug Alcohol Depend; 2013 Sep; 132(1-2):387-90. PubMed ID: 23642316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
    Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
    BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control study.
    Prilutskaya M; Bersani FS; Corazza O; Molchanov S
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients.
    Hasin DS; Fenton MC; Beseler C; Park JY; Wall MM
    Drug Alcohol Depend; 2012 Apr; 122(1-2):28-37. PubMed ID: 21963333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-(-)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder
    Witkin JM; Kranzler J; Kaniecki K; Popik P; Smith JL; Hashimoto K; Sporn J
    Pharmacol Biochem Behav; 2020 Jul; 194():172927. PubMed ID: 32333922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of dual substance abuse and dependence.
    Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
    CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS).
    Kwan ATH; Rosenblat JD; Mansur RB; Teopiz KM; McIntyre RS
    J Affect Disord; 2024 Sep; 360():421-426. PubMed ID: 38795777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in the pharmacotherapy of substance abuse.
    O'Brien CP
    J Consult Clin Psychol; 1996 Aug; 64(4):677-86. PubMed ID: 8803357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.